Thrombocytopenic purpura, immune

Clinical trials for Thrombocytopenic purpura, immune explained in plain language.

Never miss a new study

Get alerted when new Thrombocytopenic purpura, immune trials appear

Sign up with your email to follow new studies for Thrombocytopenic purpura, immune, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

New hope for rare bleeding disorder: experimental drug JCXH-213 enters human trials

Disease control Not yet recruiting

This early-stage study tests a new drug called JCXH-213 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The trial includes only 4 people whose ITP did not improve with standard treatments. The main goal is to…

Matched conditions: THROMBOCYTOPENIC PURPURA, IMMUNE

Phase 1 • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

Thrombocytopenic purpura, immune

Get alerted when new Thrombocytopenic purpura, immune trials appear

New hope for rare bleeding disorder: experimental drug JCXH-213 enters human trials